Fort Lauderdale, FL, United States of America

Min Wu

This inventor holds 18 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 7 EPO patents, primarily in Robotic Surgery. Top assignees: Mako Surgical Corporation, Fibrogen, Inc.. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min Wu. Retrieved from https://idiyas.com/inventor/min-wu-8g78hkxc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 3)

% Patents Active = 94.4

CIPO Patents = 4 (Patent Applications = 7)

EPO Patents = 7 (Patent Applications = 3)

Average Co-Inventor Count = 4.2

ph-index = 8

Forward Citations = 263(Granted Patents)

Location History:

Davie, FL (US) (2009 - 2012)
Sunnyvale, CA (US) (2010 - 2016)
Fort Lauderdale, FL (US) (2014 - 2024)
Weston, FL (US) (2022 - 2024)

Company Filing History:

10 out of 486

Mako Surgical Corporation

Years Active: 2009-2025

Loading Chart...

Areas of Expertise:

Robotic-Assisted Surgery

Revision Procedure

Fiber Optic Tracking

HIF Inhibitors

Image Segmentation

Isoquinoline Compounds

Pyridine Derivatives

Contour Propagation

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12343093 - Systems and methods for guiding a revision procedure (2025-07-01),

2. 11944392 - Systems and methods for guiding a revision procedure (2024-04-02),

3. 11857270 - Systems and methods for a robotic-assisted revision procedure (2024-01-02),

4. 11819294 - Systems and methods for fiber optic tracking (2023-11-21),

5. 11484368 - Systems and methods for a robotic-assisted revision procedure (2022-11-01),

6. 11478307 - Systems and methods for fiber optic tracking (2022-10-25),

7. 10716630 - Systems and methods for a robotic-assisted revision procedure (2020-07-21),

8. 9409892 - 4-hydroxy-isoquinoline compounds as HIF hydroxylase inhibitors (2016-08-09),

9. 9387200 - Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity (2016-07-12),

10. 9174976 - Cyanoisoquinoline compounds and methods of use thereof (2015-11-03),

11. 8952160 - Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity (2015-02-10),

12. 8759373 - Cyanoisoquinoline compounds and methods of use thereof (2014-06-24),

13. 8704827 - Cumulative buffering for surface imaging (2014-04-22),

14. 8269008 - Oxazolopyridine and isoxazolopyridine derivatives for use in the treatment of HIF-mediated conditions (2012-09-18),

15. 8249345 - Automatic image segmentation using contour propagation (2012-08-21),

Title: Min Wu: Innovator in Revision Procedures

Introduction

Min Wu, based in Fort Lauderdale, Florida, is a prolific inventor with a remarkable portfolio of 18 patents. His work focuses primarily on advanced methods and systems in the medical field, particularly in guiding surgical procedures for revision implants.

Latest Patents

Among his most recent innovations are two significant patents relating to surgical revisions. The first patent outlines a method for intraoperatively augmenting a revision implant, which includes removing a primary implant from the bone, assessing the size of a bone defect during surgery, cutting bone filler material to the specific measurement, and then installing both the filler material and the revision implant. The second patent focuses on the planning and execution of revision arthroplasty procedures. This innovation captures the positions of a tracked probe as it touches various points on a primary implant component, which allows for the generation of a virtual representation of the interface with the bone. This aids in planning the necessary bone resection and guiding its execution during surgery.

Career Highlights

Min Wu has made significant contributions during his career, having worked with notable companies such as Mako Surgical Corporation and Fibrogen, Inc. His expertise in surgical technologies exemplifies his commitment to improving patient outcomes in the field of medicine.

Collaborations

Throughout his career, Min has collaborated with esteemed colleagues, including Michael P. Arend and Lee Allen Flippin. These partnerships have further fueled innovation and the practical application of his ideas in the medical device industry.

Conclusion

Min Wu is a distinguished inventor whose contributions to the field of revision procedures have the potential to revolutionize surgical practices. With a strong background in his area of expertise and a dedication to advancing medical technology, his innovations continue to pave the way for improved surgical outcomes and enhanced patient care.

Profile summary based on public USPTO records.